Project Grant R35GM155239

Award Date 8/1/24
Completion Date 5/31/29
Dollars Obligated $1.2M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $189,150.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to identify new mediators of proinflammatory cytokine signaling. The goal is to better understand how interleukin-1β (IL-1β) and tumor necrosis factor-α (TNFα) compromise Akt signaling, which regulates a range...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $971,109 over approximately 3 years starting June 2025 to researchers at the University of California, Merced. The project will study the binding dynamics and oligomerization of DNA sensor proteins AIM2 and IFI16, which are involved in pathogen detection and inflammatory signaling. Using advanced microscopy techniques,...
This Project Grant award of $405,497.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to develop a compact viral system for robust, concurrent CRISPR activation and interference (CRISPRa/i) in primary murine immune cells. The goal is to use this system to map the gene regulatory network controlling BCL11B activation and T cell lineage commitment. Key innovations include CRISPR RNA-scaffolds to recruit...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $195,894.00 to The Washington University to study the mechanisms contributing to T cell dysregulation in STAT3 gain-of-function (GOF) syndrome. The primary scientific goal is to investigate critical interactions between T and B cells, as well as the development, polarization, and function of these cells, in order to...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $479,249 to Washington University to conduct research on the molecular mechanisms regulating neutrophil proinflammatory activity in sepsis. The research aims to understand how neutrophil A20 signaling contributes to organ damage in sepsis, utilizing biochemical, cell biological, and intravital imaging...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $238,620 to Albany Medical College to conduct research on the role of protein kinase C epsilon (PKCε) in regulating inflammation and resolution processes related to atherosclerosis. The goal of the 2-year project is to investigate how myeloid cell-specific deletion of PKCε impacts the progression of atherosclerosis...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $130,932 to Harvard Medical School to elucidate the molecular mechanisms underlying the activation and regulation of the inflammasome executioner protein Gasdermin D (GSDMD). The research aims to interrogate this complex system through a combination of biochemistry, biophysics, and cell biology, with the goal...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,269,762 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Northwestern University. The grant will fund the development of a microfluidic platform for high-performance sorting of immune cells based on their distinct secretion patterns. This technology, referred to as SECRE (Secretion-Enabled Cell Ranking and Enrichment), will be used in conjunction with next-generation sequencing...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $244,440 to the Albert Einstein College of Medicine to investigate the mechanisms by which LY6C+ monocytes respond to and help clear microbial pathogen infections. The research aims to define the chemotactic cues, receptors, and molecular processes involved in how these monocytes home to infection sites and form stable...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Grant Program (CFDA 93.855), provides $639,485 to the University of Alabama at Birmingham (UAB) to conduct research on the mechanisms of STAT1 and STAT3 activation and their role in immune function and disease. The key objectives of this 5-year research project are to: 1) Decipher the molecular mechanisms by which activated STAT1 and STAT3...

DISSECTING THE MOLECULAR MECHANISM OF CYTOKINE ACTIVATION AND SPATIOTEMPORAL REGULATION OF INNATE IMMUNITY - PROJECT SUMMARY AND ABSTRACT MACROMOLECULAR SIGNALING COMPLEXES PLAY FUNDAMENTAL ROLES IN BIOLOGY, RANGING FROM THE CONTROL OF DEVELOPMENT TO REGULATION OF THE IMMUNE SYSTEM. THE INFLAMMASOME IS AN EXAMPLE OF A MACROMOLECULAR SIGNALING PLATFORM THAT ACTIVATES THE INNATE IMMUNE SYSTEM IN RESPONSE TO INVADING PATHOGENS OR ENDOGENOUS HOST-DERIVED DANGER SIGNALS. AS THE INNATE IMMUNE SYSTEM REGULATES INFLAMMATION AND HAS CROSSTALK WITH THE ADAPTIVE IMMUNE SYSTEM, DYSREGULATION OF INFLAMMASOME SIGNALING IS ASSOCIATED WITH AUTOINFLAMMATORY AND AUTOIMMUNE DISORDERS. ACTIVATION OF THE INFLAMMASOME INVOLVES THE RECOGNITION OF INTRACELLULAR DANGER SIGNALS BY GERMLINE- ENCODED PATTERN RECOGNITION RECEPTORS THAT THEN RECRUIT AN ADAPTOR PROTEIN KNOWN AS ASC (ALTHOUGH IN SOME INSTANCES ASC IS DISPENSABLE) TO FORM THE INFLAMMASOME. ASC THEN RECRUITS A CYSTEINE PROTEASE KNOWN AS CASPASE-1 TO THE INFLAMMASOME WHERE IT UNDERGOES AUTOPROTEOLYTIC MATURATION. ACTIVE CASPASE-1 THEN CLEAVES SUBSTRATES THAT ARE IMPORTANT FOR RESTORING CELLULAR HOMEOSTASIS, INCLUDING THE INTERLEUKIN FAMILY OF CYTOKINES, IL- 1 AND IL-18, AND THE PORE FORMING PROTEIN GSDMD TO INDUCE A LYTIC TYPE OF CELL DEATH KNOWN AS PYROPTOSIS. THE MECHANISM OF HOW INFLAMMASOMES ARE ASSEMBLED, IN PARTICULAR, HOW THE DIFFERENT PROTEINS ARE ORGANIZED IN SPACE AND TIME TO ENSURE PROPER FUNCTION, IS NOT WELL UNDERSTOOD. OF NOTE, THE INCORPORATION OF ASC ON THE INFLAMMASOME IS REQUIRED FOR CYTOKINE PROCESSING, BUT THE MECHANISM OF HOW ASC INDUCES CYTOKINE ACTIVATION HAS REMAINED UNCLEAR FOR OVER A DECADE. ADDITIONALLY, SOME INFLAMMASOMES ARE ASC-INDEPENDENT BUT CAN FORM ASC-CONTAINING INFLAMMASOMES. HOW THESE INFLAMMASOMES DECIDE WHEN TO FORM AN ASC-INDEPENDENT OR ASC CONTAINING INFLAMMASOME IS A MYSTERY. THE GOAL OF THIS PROPOSAL IS TO ADDRESS THESE FUNDAMENTAL QUESTIONS IN INNATE IMMUNITY. WE WILL ELUCIDATE THE MECHANISM OF CYTOKINE ACTIVATION AND DELINEATE THE SPATIOTEMPORAL REGULATION OF INFLAMMASOMES. TO ACCOMPLISH THIS, WE HAVE DEVELOPED NEW TOOLS THAT WILL ALLOW US TO BUILD A SPATIOTEMPORAL MAP OF INFLAMMASOME FORMATION AND SIGNALING, WHICH WILL PROVIDE KEY MECHANISTIC INSIGHTS TO AID THERAPEUTIC DEVELOPMENT FOR IMMUNE RELATED DISORDERS. FURTHERMORE, WE ANTICIPATE THESE TOOLS WILL BECOME IMPORTANT BIOMEDICAL RESEARCH TOOLS.

Posted 7/22/24